Previously reported pharmacological activity of Bixa orellana L. (Bixaceae) includes its ability to neutralize edema-forming effects of Bothrops asper venom (Nunez V., et al, 2004). Study on the mechanism of its anti-edema activity is thus far lacking. The purpose of this study was to examine the effects of aqueous extract of B. orellana (AEBO) leaves on endothelial permeability and the permeability-regulator molecule, nitric oxide (NO), during inflammatory stimulation by histamine. This study demonstrated that AEBO (0.1mg/ml -0.4mg/ml) significantly (p&lt;0.05) suppressed histamine-induced increased endothelial permeability in human umbilical veins endothelial cells (HUVECs), where maximal inhibition was 90.2% at concentration and time point of 0.4mg/ml and 15min, respectively. Histamine-mediated NO formation in HUVECs was significantly reduced by all concentration of AEBO in a dose-dependent manner. 0.4mg/ml showed maximal inhibition where it reduced NO level from 12.51±0.07µM to 11.3±0.07µM (65.4% inhibition). On the other hand, 0.1 and 0.2mg/ml of AEBO suppressed NO production at 21.70% and 34.50%, respectively. To verify that AEBO will produce similar effects to exogenous source of NO as to endogenous NO, NO donor, sodium nitroprusside (SNP) was used. AEBO showed significant effects in scavenging NO radicals released by SNP where maximal inhibition was 51.2% at 0.4mg/ml. These results indicate that AEBO suppressed increased endothelial permeability by re-establishing normal NO production in HUVECs. This study justifies the use of Bixa orellana in traditional medicine by showing its potential in regulating endothelial cell barrier function.
